A humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicity

Abstract Background Agonistic monoclonal antibodies targeting 4-1BB/CD137 have shown preclinical promise, but their clinical development has been limited by severe liver toxicity or limited efficacy. Therefore, a safe and efficient immunostimulatory molecule is urgently needed for cancer immunothera...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Da-yan Zhang, Zhi-hua Zhang, Wen-ting Liu, Wei-ming Zhou, Peng-fei Zhou, Juan-juan Wei, Xue-jing Dai, Xiao-li Zeng, Yu-qiong Zhou, Han-wang Li, Heng Zhang, Ao-lin Shen, Lian-sheng Cheng, Guo-dong Shen, Yi-fu He
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2025-01-01
Schriftenreihe:	Journal of Translational Medicine
Schlagworte:	4-1BB/CD137 MSLN Bispecific antibody Cancer immunotherapy Antitumour immunity
Online-Zugang:	https://doi.org/10.1186/s12967-025-06107-z
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!